| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ... Nature 507 (7490), 109-113, 2014 | 664 | 2014 |
| Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ... Cancer discovery 4 (6), 674-687, 2014 | 287 | 2014 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 249 | 2017 |
| MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy J Reinhardt, J Landsberg, JL Schmid-Burgk, BB Ramis, T Bald, N Glodde, ... Cancer research 77 (17), 4697-4709, 2017 | 159 | 2017 |
| Anti‐inflammatory activity of topical THC in DNFB‐mediated mouse allergic contact dermatitis independent of CB 1 and CB 2 receptors E Gaffal, M Cron, N Glodde, T Tüting Allergy 68 (8), 994-1000, 2013 | 109 | 2013 |
| Lineage-restricted regulation of SCD and fatty acid saturation by MITF controls melanoma phenotypic plasticity Y Vivas-García, P Falletta, J Liebing, P Louphrasitthiphol, Y Feng, ... Molecular cell 77 (1), 120-137. e9, 2020 | 106 | 2020 |
| Differential role of cannabinoids in the pathogenesis of skin cancer N Glodde, M Jakobs, T Bald, T Tüting, E Gaffal Life Sciences 138, 35-40, 2015 | 69 | 2015 |
| Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation E Gaffal, M Cron, N Glodde, T Bald, R Kuner, A Zimmer, B Lutz, T Tüting The Journal of Immunology 190 (10), 4929-4936, 2013 | 57 | 2013 |
| Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate‐induced mouse atopic‐like dermatitis E Gaffal, N Glodde, M Jakobs, T Bald, T Tüting Experimental dermatology 23 (6), 401-406, 2014 | 40 | 2014 |
| A preclinical model of malignant peripheral nerve sheath tumor-like melanoma is characterized by infiltrating mast cells M Hoelzel, J Landsberg, N Glodde, T Bald, M Rogava, S Riesenberg, ... Cancer research 76 (2), 251-263, 2016 | 36 | 2016 |
| Adoptive T cell therapy targeting different gene products reveals diverse and context-dependent immune evasion in melanoma M Effern, N Glodde, M Braun, J Liebing, HN Boll, M Yong, E Bawden, ... Immunity 53 (3), 564-580. e9, 2020 | 33 | 2020 |
| RAS and PD-L1: a masters’ liaison in cancer immune evasion N Glodde, M Hölzel Immunity 47 (6), 1007-1009, 2017 | 20 | 2017 |
| β-arrestin 2 inhibits proinflammatory chemokine production and attenuates contact allergic inflammation in the skin E Gaffal, M Jakobs, N Glodde, R Schröder, E Kostenis, T Tüting Journal of Investigative Dermatology 134 (8), 2131-2137, 2014 | 13 | 2014 |
| Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation. Cancer Discov. 2014; 4: 674–87. doi: 10.1158/2159-8290 T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ... CD-13-0458, 0 | 13 | |
| Targeting inflamed and non-inflamed melanomas: biological background and clinical challenges A Indini, D Massi, M Pirro, F Roila, F Grossi, A Sahebkar, N Glodde, ... Seminars in Cancer Biology 86, 477-490, 2022 | 12 | 2022 |
| The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy J Ruotsalainen, D Lopez‐Ramos, M Rogava, N Shridhar, N Glodde, ... Clinical & Translational Immunology 10 (4), e1276, 2021 | 6 | 2021 |
| Experimental and stochastic models of melanoma T-cell therapy define impact of subclone fitness on selection of antigen loss variants N Glodde, A Kraut, D van den Boorn-Konijnenberg, S Vadder, F Kreten, ... bioRxiv, 860023, 2019 | 6 | 2019 |
| CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models M Effern, N Glodde, E Bawden, J Liebing, D Hinze, T Tüting, T Gebhardt, ... STAR protocols 3 (1), 101038, 2022 | 2 | 2022 |
| A preclinical model of malignant peripheral nerve sheath tumor-like is characterized by infiltrating mast cells M Hölzel, J Landsberg, N Glodde, T Bald, M Rogava, S Riesenberg, ... | | |
